Vision therapy helps brain injury patients

Article

Stroke and traumatic brain injury survivors, who have undergone vision restoration therapy (VRT), demonstrate increased brain activity, according to researchers from Columbia University Medical Center, USA.

Stroke and traumatic brain injury survivors, who have undergone vision restoration therapy (VRT), demonstrate increased brain activity, according to researchers from Columbia University Medical Center, USA.

Randolph Marshall and colleagues examined the functional magnetic resonance imaging (fMRIs) of six patients aged between 35 and 77 with homonymous hemianopia vision loss caused by stroke or traumatic brain injury. Each patient underwent VRT therapy to help rehabilitate their vision.

The fMRI data showed that there was an increased activity in the visual processing areas of the brain as patients learned to detect stimuli in the border zone between the seeing and non-seeing fields. This enhanced activity was identified one month after the start of treatment, suggesting that the brain responds accordingly.

The treatment involves patients performing daily therapy at home for between six and seven months, gradually improving their vision through repeated detection of light stimuli directed at the border between the seeing and blind areas of the visual field.

Recent Videos
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
3 experts are featured in this series.
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Sunita Radhakrishnan, MD, an associate at the Glaucoma Center of San Francisco, speaks at the annual Glaucoma 360 meeting about electrical neurostimulation.
3 experts are featured in this series.
3 experts are featured in this series.
Related Content
© 2025 MJH Life Sciences

All rights reserved.